Cargando…
Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692833/ https://www.ncbi.nlm.nih.gov/pubmed/34955865 http://dx.doi.org/10.3389/fphar.2021.813471 |
| _version_ | 1784619017121562624 |
|---|---|
| author | Otero-Losada, Matilde Gubellini, Paolo Capani, Francisco Perez-Lloret, Santiago |
| author_facet | Otero-Losada, Matilde Gubellini, Paolo Capani, Francisco Perez-Lloret, Santiago |
| author_sort | Otero-Losada, Matilde |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8692833 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86928332021-12-23 Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease Otero-Losada, Matilde Gubellini, Paolo Capani, Francisco Perez-Lloret, Santiago Front Pharmacol Pharmacology Frontiers Media S.A. 2021-12-08 /pmc/articles/PMC8692833/ /pubmed/34955865 http://dx.doi.org/10.3389/fphar.2021.813471 Text en Copyright © 2021 Otero-Losada, Gubellini, Capani and Perez-Lloret. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Otero-Losada, Matilde Gubellini, Paolo Capani, Francisco Perez-Lloret, Santiago Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease |
| title | Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease |
| title_full | Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease |
| title_fullStr | Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease |
| title_full_unstemmed | Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease |
| title_short | Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease |
| title_sort | editorial: neuroprotection and disease modification in parkinson’s disease |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692833/ https://www.ncbi.nlm.nih.gov/pubmed/34955865 http://dx.doi.org/10.3389/fphar.2021.813471 |
| work_keys_str_mv | AT oterolosadamatilde editorialneuroprotectionanddiseasemodificationinparkinsonsdisease AT gubellinipaolo editorialneuroprotectionanddiseasemodificationinparkinsonsdisease AT capanifrancisco editorialneuroprotectionanddiseasemodificationinparkinsonsdisease AT perezlloretsantiago editorialneuroprotectionanddiseasemodificationinparkinsonsdisease |